Shares in Aortech International, the developer of a polymer for medical devices, fell following the announcement that it is in dispute with its largest customer, St Jude Medical.
The dispute centres around the use that St Jude Medical is making of Optim, which is actually Elasteon supplied by Aortech. Aortech alleges that there has been a "material breach of contract" by St Jude Medical.
Chairman Bill Brown explained that the material is used to insulate pacemakers, but declined to explain the exact nature of the breach of contract.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It is the latest blow in a long-running saga that has given investors a white knuckle ride over the past year, during which its share price hit a high of 371p before plummeting.
In late September, Aortech's shares halved after warning that takeover talks had collapsed and that it was investigating funding options.
CM
-
Frozen thresholds could push ‘tax freedom day’ to latest date this centuryTax freedom day is the point in the year you stop earning for the taxman and start earning for yourself. A rising tax burden could push it to 12 June this year – the latest date since 1982.
-
Family left with £20k IHT bill because of out-of-date tax adviceFrozen tax thresholds and dated guidance helped drag the estate into an inheritance tax liability despite extensive use of gifting to avoid a bill
